ProMetic Life Sciences is a worldwide biopharmaceutical company that specializes in designing small molecules that mimic unique and specific interactions between proteins, research, development, manufacturing and marketing of various commercial applications derived from its proprietary Mimetic Ligand technology. The company uses this technology in the large-scale purification of biologics, in drug development, in proteomics and in eliminating pathogens. The company is also actively developing its own novel therapeutic products. For more information, visit the company’s Web site at www.prometic.com.

The BIO CEO & Investor Conference is the largest investor conference focused on established and emerging publicly traded biotech companies. Each year the annual event provides a neutral forum where institutional investors, industry analysts, and senior biotechnology executives have the opportunity to shape the future investment landscape of the biotechnology industry. For more information on Biotechnology Industry Organization (BIO), visit www.bio.org.

Let us hear your thoughts below: